← Open Payments lookup

AMANDA DOZIER: Open Payments

NPI 1548644099 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$200 in 12 payments from 10 companies in 2025. Trend: 2023 $375 · 2024 $289 · 2025 $200

Food & beverage: $200
CompanyPaymentsAmount
Viatris Specialty LLC3$47
Exeltis, USA Inc.1$22
Novo Nordisk Inc1$22
Otsuka America Pharmaceutical, Inc.1$18
Xeris Pharmaceuticals, Inc.1$17
Amgen Inc.1$17
AstraZeneca Pharmaceuticals LP1$16
SANOFI PASTEUR INC.1$15
PFIZER INC.1$14
Corium, LLC1$12

Products named: YUPELRI, SLYND, Ozempic, REXULTI, RECORLEV, EVENITY, FARXIGA, BEYFORTUS.

Industry payments across ID — which companies pay providers there.